Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal CarcinomaYuan Zhang, Jun Ma, Lei Chen et al.|New England Journal of Medicine|2019Cited by 934
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trialFeng Wang, Rui‐Hua Xu, Miao‐Zhen Qiu et al.|Nature Medicine|2024Cited by 162
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratioXiaoli Wei, Rui‐Hua Xu, Feng‐Hua Wang et al.|BMC Cancer|2015Cited by 160
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III TrialYuan Zhang, Ling‐Long Tang, Lei Chen et al.|Journal of Clinical Oncology|2022Cited by 147
Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patientsMiao‐Zhen Qiu, Rui‐Hua Xu, Yixin Zhou et al.|BMC Cancer|2014Cited by 70